PsychedelicNewsBreaks — Green Label Summit 2023 to Showcase Insights and Innovations Shaping the Future of Cannabis

The highly-anticipated Green Label Summit 2023, hosted by Jotia Group, is set to shine in the shimmering lights of Las Vegas on Sept. 13 – 14 at The Expo, World Market Center. The event is designed to deliver an unparalleled platform for dynamic discussions and visionary insights into the ever-evolving cannabis industry. The summit will feature the Psychedelic Horizons Forum, captivating sessions and masterclasses, with a special emphasis on the future of cannabis. Throughout the event, experts will share invaluable market predictions and insights into medical advancements, product development, evolving regulations, consumer choices, tourism, cultivation and growing green, and cutting-edge innovations in marketing technologies that are shaping the future of the industry. “There has never been a greater need for an inclusive event than this. In order to move forward for the greater good of all, we must work together,” Founder and Director John Richard said of the event. “The reconciliation between consumption, consumerism and medical needs, spiritual growth and cultural respect in conjunction with compliance and business growth- I see a great vision for this industry, and I am honored to speak with and be part of this community.”

To view the full press release, visit https://ibn.fm/wWTZs

About Green Label Summit 2023

Hosted by Jotia Group, the Green Label Summit 2023 will feature renowned speakers, masterclasses, panel sessions and forums that highlight the dynamic cannabis industry and insights into its future. Topics will include unlocking financial success, advancements in medical cannabis and psychedelics, cannabis criminal justice reform and reentry, fostering inclusion, innovative technology, the art and science of cannabis cultivation, and more. Throughout the event, participants will have the unique opportunity to connect with others at the Green Label Collective, fostering new relationships and exploring avenues for active involvement in this dynamic movement. For more information and to purchase tickets for the summit, visit https://ibn.fm/7Hr2h.

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)

For more information please visit https://www.psychedelicnewswire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.

Chris@PNW

Share
Published by
Chris@PNW

Recent Posts

PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Forms Investor Relations Partnership With astr Partners

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, and its subsidiary HOPE Therapeutics announced a…

22 hours ago

PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) and HOPE Therapeutics to Present at H.C. Wainwright Neuro Perspectives Conference

NRx Pharmaceuticals (NASDAQ: NRXP) and its wholly owned subsidiary HOPE Therapeutics, Inc. announced participation in…

5 days ago

PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Files ANDA for Preservative-Free IV Ketamine, Targets Expanding $750M Market 

  NRx Pharmaceuticals (NASDAQ: NRXP), has submitted an Abbreviated New Drug Application (ANDA) to the…

2 weeks ago

PsychedelicNewsBreaks – Rythmia Life Advancement Center Unveils Affiliate Program for Wellness Advocates

Rythmia Life Advancement Center, the world’s first medically licensed ayahuasca retreat, has launched an affiliate…

2 weeks ago

PsychedelicNewsBreaks – Lophora ApS Doses First Subjects in Phase 1 Trial of Psychedelic-Based CNS Drug LPH-5 

Lophora, a Danish biotech advancing next-generation psychedelic therapies, announced the first subjects have been dosed…

3 weeks ago

PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Present at Wall Street Conference on May 21

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, announced that Founder and CEO Dr. Jonathan…

4 weeks ago